Control Bionics Limited provided revenue guidance for the year ended 30 June 2023. The revenue for the year ended 30 June 2023 is expected to be approximately $5.3 million, a more than 20% increase in the revenue of $4.4 million for the year ended 30 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.052 AUD | +8.33% |
|
+4.00% | +13.04% |
Jun. 20 | Control Bionics' DROVE Autonomous Wheelchair Module Secures Australia Approval | MT |
May. 17 | Control Bionics Raises AU$130,000 via Additional Commitments for Placement | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.04% | 7.04M | |
-27.91% | 16.33B | |
-56.07% | 2.17B | |
+19.09% | 1.88B | |
-12.63% | 1.45B | |
+29.99% | 1.32B | |
+8.32% | 853M | |
-30.60% | 799M | |
-36.50% | 726M | |
+29.48% | 622M |
- Stock Market
- Equities
- CBL Stock
- News Control Bionics Limited
- Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023